Jailendra Singh
Stock Analyst at Truist Financial
(0.19)
# 4,573
Out of 4,707 analysts
780
Total ratings
42.8%
Success rate
-5.4%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintained: Hold | n/a | $10.22 | - | 27 | Sep 3, 2026 | |
| FTRE Fortrea Holdings | Maintained: Buy | n/a | $17.06 | - | 15 | Sep 3, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | n/a | $6.26 | - | 65 | Sep 1, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $33 | $24.24 | +36.14% | 17 | Aug 27, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | n/a | $264.84 | - | 38 | Aug 26, 2026 | |
| MDLN Medline | Reiterated: Buy | n/a | $34.69 | - | 8 | Aug 26, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $32 | $28.17 | +13.60% | 61 | Aug 25, 2026 | |
| AGL agilon health | Maintained: Hold | n/a | $91.37 | - | 35 | Aug 24, 2026 | |
| GDRX GoodRx Holdings | Reiterated: Hold | n/a | $3.52 | - | 42 | Aug 14, 2026 | |
| PGNY Progyny | Reiterated: Buy | $36 | $27.15 | +32.60% | 47 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $13.34 | -10.04% | 38 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $20.78 | +58.81% | 39 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 | $24.42 | -1.72% | 30 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $6 | $4.22 | +42.18% | 53 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $38.10 | +44.36% | 30 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $112 | $92.69 | +20.83% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $33.88 | +23.97% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.51 | - | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $209 | $158.34 | +31.99% | 36 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $259.21 | +15.74% | 47 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $609 | $590.89 | +3.06% | 19 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.75 | - | 1 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $207.32 | -44.05% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.18 | n/a | 3 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.86 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.28 | n/a | 1 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $64.58 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $275.83 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $401.94 | n/a | 1 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $57.42 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.37 | n/a | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $403.09 | n/a | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.66 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.54 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,123.91 | n/a | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $402.02 | n/a | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $22 | $39.31 | n/a | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $610 | $400.84 | n/a | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $31 → $16 | $0.9757 | n/a | 19 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $42 → $43 | $1.10 | n/a | 12 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $24 | $1.02 | n/a | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $4 | $0.5354 | n/a | 9 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $180 | $324.69 | n/a | 14 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $62 | $240.49 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $230 → $333 | $889.12 | n/a | 12 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 → $3.5 | $4.29 | n/a | 4 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $21 | $33.01 | n/a | 4 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $171.82 | n/a | 1 | Feb 26, 2020 |
Phreesia
Sep 3, 2026
Maintained: Hold
Price Target: n/a
Current: $10.22
Upside: -
Fortrea Holdings
Sep 3, 2026
Maintained: Buy
Price Target: n/a
Current: $17.06
Upside: -
Teladoc Health
Sep 1, 2026
Maintained: Hold
Price Target: n/a
Current: $6.26
Upside: -
Waystar Holding
Aug 27, 2026
Reiterated: Buy
Price Target: $33
Current: $24.24
Upside: +36.14%
Veeva Systems
Aug 26, 2026
Maintained: Buy
Price Target: n/a
Current: $264.84
Upside: -
Medline
Aug 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.69
Upside: -
Hims & Hers Health
Aug 25, 2026
Reiterated: Hold
Price Target: $32
Current: $28.17
Upside: +13.60%
agilon health
Aug 24, 2026
Maintained: Hold
Price Target: n/a
Current: $91.37
Upside: -
GoodRx Holdings
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.52
Upside: -
Progyny
Aug 13, 2026
Reiterated: Buy
Price Target: $36
Current: $27.15
Upside: +32.60%
Aug 13, 2026
Reiterated: Hold
Price Target: $12
Current: $13.34
Upside: -10.04%
Aug 13, 2026
Maintained: Buy
Price Target: $33
Current: $20.78
Upside: +58.81%
Aug 13, 2026
Maintained: Hold
Price Target: $24
Current: $24.42
Upside: -1.72%
Aug 12, 2026
Rated: Hold
Price Target: $7 → $6
Current: $4.22
Upside: +42.18%
Aug 11, 2026
Reiterated: Buy
Price Target: $55
Current: $38.10
Upside: +44.36%
Aug 11, 2026
Rated: Buy
Price Target: $112
Current: $92.69
Upside: +20.83%
Aug 10, 2026
Reiterated: Buy
Price Target: $42
Current: $33.88
Upside: +23.97%
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $1.51
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: $207 → $209
Current: $158.34
Upside: +31.99%
Jul 29, 2026
Reiterated: Buy
Price Target: $300
Current: $259.21
Upside: +15.74%
Jul 28, 2026
Maintained: Hold
Price Target: $609
Current: $590.89
Upside: +3.06%
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.75
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: $116
Current: $207.32
Upside: -44.05%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $8.18
Upside: n/a
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $8.86
Upside: n/a
Jul 17, 2025
Maintained: Buy
Price Target: n/a
Current: $17.28
Upside: n/a
Jul 2, 2025
Maintained: Buy
Price Target: n/a
Current: $64.58
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $275.83
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $401.94
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $57.42
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: n/a
Current: $1.37
Upside: n/a
Oct 3, 2024
Rated: Hold
Price Target: n/a
Current: $403.09
Upside: n/a
Sep 9, 2024
Maintained: Hold
Price Target: n/a
Current: $13.66
Upside: n/a
Sep 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.54
Upside: n/a
Jul 3, 2024
Maintained: Buy
Price Target: n/a
Current: $1,123.91
Upside: n/a
Apr 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $402.02
Upside: n/a
Apr 16, 2024
Maintained: Hold
Price Target: $21 → $22
Current: $39.31
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $610
Current: $400.84
Upside: n/a
Mar 3, 2022
Maintained: Hold
Price Target: $31 → $16
Current: $0.9757
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $42 → $43
Current: $1.10
Upside: n/a
Feb 24, 2022
Maintained: Hold
Price Target: $30 → $24
Current: $1.02
Upside: n/a
Feb 8, 2022
Downgraded: Hold
Price Target: $14 → $4
Current: $0.5354
Upside: n/a
Jan 7, 2022
Maintained: Buy
Price Target: $145 → $180
Current: $324.69
Upside: n/a
Jan 7, 2022
Maintained: Hold
Price Target: $50 → $62
Current: $240.49
Upside: n/a
Jan 7, 2022
Upgraded: Buy
Price Target: $230 → $333
Current: $889.12
Upside: n/a
Jan 7, 2022
Downgraded: Sell
Price Target: $9 → $3.5
Current: $4.29
Upside: n/a
Nov 11, 2021
Maintained: Buy
Price Target: $26 → $21
Current: $33.01
Upside: n/a
Feb 26, 2020
Maintained: Buy
Price Target: $30
Current: $171.82
Upside: n/a